← Evidence map

TrialRheumatology (Oxford, England)2016

Muscle myeloid type I interferon gene expression may predict therapeutic responses to rituximab in myositis patients.

Kanneboyina Nagaraju et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

7 papers cite it

2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 27215813